Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.

Authors

Justin D Arnold, George Washington UniversityFollow
Eleanor P Sarkodie
Megan E Coleman
Deborah A Goldstein

Document Type

Journal Article

Publication Date

11-1-2016

Journal

J Sex Med

Volume

13

Issue

11

Inclusive Pages

1773-1777

DOI

10.1016/j.jsxm.2016.09.001

Keywords

Administration, Oral; Adult; Androgen Antagonists; Cyproterone Acetate; District of Columbia; Estradiol; Estrogens; Europe; Female; Gender Identity; Gonadal Steroid Hormones; Humans; Incidence; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Retrospective Studies; Risk Factors; Spironolactone; Transgender Persons; Transsexualism; Venous Thrombosis

APA Citation

Arnold, J., Sarkodie, E., Coleman, M., & Goldstein, D. (2016). Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.. J Sex Med, 13 (11). http://dx.doi.org/10.1016/j.jsxm.2016.09.001

Peer Reviewed

1